President Donald Trump announced Friday that Medicare will begin covering GLP-1 medications used for weight loss and diabetes treatment starting July 1st.
The President made the announcement while speaking in The Villages, Florida, stating that the federal government is taking steps to make these drugs accessible to elderly Americans enrolled in the Medicare program.
The move would expand coverage for medications that have gained popularity for their effectiveness in treating both diabetes and obesity among seniors.
